Evidence map›Paper›PMID 34469715›Full record

ArticleCell reports2021

Agonists and allosteric modulators promote signaling from different metabotropic glutamate receptor 5 conformations.

Chady Nasrallah, Giuseppe Cannone, Julie Briot, Karine Rottier, Alice E Berizzi, Chia-Ying Huang, Robert B Quast, Francois Hoh, Jean-Louis Banères, Fanny Malhaire and 11 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
5.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Control of G protein-coupled receptor function via membrane-interacting intrinsically disordered C-terminal domains.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 6 institutions in 5 countries.

Chady NasrallahIGF, Université de Montpellier, CNRS, INSERM, 34094 Montpellier, France.
Giuseppe CannoneMRC Laboratory of Molecular Biology, Cambridge CB2 0QH, UK.
Julie BriotIGF, Université de Montpellier, CNRS, INSERM, 34094 Montpellier, France.
Karine RottierIGF, Université de Montpellier, CNRS, INSERM, 34094 Montpellier, France.
Alice E BerizziIGF, Université de Montpellier, CNRS, INSERM, 34094 Montpellier, France.
Chia-Ying HuangSwiss Light Source, Paul Scherrer Institute, 5232 Villigen, Switzerland.
Robert B QuastCBS, Université de Montpellier, CNRS, INSERM, 34094 Montpellier, France.
Francois HohCBS, Université de Montpellier, CNRS, INSERM, 34094 Montpellier, France.
Jean-Louis BanèresIBMM, Université de Montpellier, CNRS, ENSCM, 34093 Montpellier, France.
Fanny MalhaireIGF, Université de Montpellier, CNRS, INSERM, 34094 Montpellier, France.
Ludovic BertoIGF, Université de Montpellier, CNRS, INSERM, 34094 Montpellier, France.
Anaëlle DumazerIGF, Université de Montpellier, CNRS, INSERM, 34094 Montpellier, France.
Joan Font-InglesMCS, Laboratory of Medicinal Chemistry and Synthesis, Institute of Advanced Chemistry of Catalonia (IQAC-CSIC), Barcelona, Spain.
Xavier Gómez-SantacanaIGF, Université de Montpellier, CNRS, INSERM, 34094 Montpellier, France; MCS, Laboratory of Medicinal Chemistry and Synthesis, Institute of Advanced Chemistry of Catalonia (IQAC-CSIC), Barcelona, Spain.
Juanlo CatenaMCS, Laboratory of Medicinal Chemistry and Synthesis, Institute of Advanced Chemistry of Catalonia (IQAC-CSIC), Barcelona, Spain; SIMChem, Synthesis of High Added Value Molecules, Institute of Advanced Chemistry of Catalonia (IQAC-CSIC), Barcelona, Spain.
Julie KniazeffIGF, Université de Montpellier, CNRS, INSERM, 34094 Montpellier, France.
Cyril GoudetIGF, Université de Montpellier, CNRS, INSERM, 34094 Montpellier, France.
Amadeu LlebariaMCS, Laboratory of Medicinal Chemistry and Synthesis, Institute of Advanced Chemistry of Catalonia (IQAC-CSIC), Barcelona, Spain.
Jean-Philippe PinIGF, Université de Montpellier, CNRS, INSERM, 34094 Montpellier, France.
Kutti R VinothkumarNational Centre for Biological Sciences TIFR, GKVK Post, Bellary Road, Bangalore 560065, India. Electronic address: vkumar@ncbs.res.in.
Guillaume LebonIGF, Université de Montpellier, CNRS, INSERM, 34094 Montpellier, France. Electronic address: guillaume.lebon@igf.cnrs.fr.
Centre National de la Recherche Scientifique · FRInstitute of Advanced Chemistry of Catalonia · ESÉcole Nationale Supérieure de Chimie de Montpellier · FRMRC Laboratory of Molecular Biology · GBNational Centre for Biological Sciences · INPaul Scherrer Institute · CH

Funding

Medical Research Council MC_U105184326
6 · The paper itself

Abstract

Metabotropic glutamate receptors (mGluRs) are dimeric G-protein-coupled receptors activated by the main excitatory neurotransmitter, L-glutamate. mGluR activation by agonists binding in the venus flytrap domain is regulated by positive (PAM) or negative (NAM) allosteric modulators binding to the 7-transmembrane domain (7TM). We report the cryo-electron microscopy structures of fully inactive and intermediate-active conformations of mGlu

Indexed as

Cryoelectron MicroscopyCrystallography, X-RayExcitatory Amino Acid AgonistsExcitatory Amino Acid AntagonistsHEK293 CellsHumansModels, MolecularProtein BindingProtein Interaction Domains and MotifsProtein StabilityProtein SubunitsReceptor, Metabotropic Glutamate 5Signal TransductionStructure-Activity RelationshipExcitatory Amino Acid AgonistsExcitatory Amino Acid AntagonistsGRM5 protein, humanProtein SubunitsReceptor, Metabotropic Glutamate 5allosteric modulatorscryo-EMglutamateG-protein-coupled receptorsmetabotropic glutamate receptor 5photochromic ligandssignal transductionX-ray crystallography

Identifiers

PMID34469715
PMCPMC8424648
OpenAlexW3196614271

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.